Stojsic, V., Zaric, B., Simurdic, P., Kovacevic, T., Bokan, D., Djekic Malbasa, J., … Nikolin, B. (2026). Real World Data Survival Outcomes of First Line Immunotherapy with Pembrolizumab in High Expressers with stage IV Non-Small Cell Lung Cancer. Radiology and Oncology, 60(3), 450–458. Retrieved from https://radioloncol.com/index.php/ro/article/view/4876